Bestqool Pro Advanced Series: Revolutionizing Red Light Therapy This Black Friday
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- With winter just around the corner, Bestqool is proud to offer a head start on wellness with their advanced Pro Series, featuring next-level red light therapy suitable for any professional settings. The Pro series is a milestone in Bestqool's mission to transform the red light therapy, using innovative, effective technology. As we are...
WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday
BOLINGBROOK, Ill. , Nov. 18, 2024 /PRNewswire/ -- Stock up your family's medicine cabinet this Black Friday and Cyber Monday. WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing in preparation for the year-end holidays. Between Nov. 24 to Dec. 2, The two-pack WELLlife COVID-19/Influenza A&B Home Test will be on sale for...
TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection
SUZHOU, China, Nov 18, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage company dedicated to developing novel therapies to address unmet needs in infectious diseases, announced today the successful completion of a phase III clinical trial of rifasutenizol (TNP-2198) for the treatment of Helicobacter pylori (H. pylori) infection. The study met its primary endpoints, showing multiple advantages of rifasutenizol regimen...
FDA Grants Breakthrough Therapy Designation to Huahui Health’s Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection
BEIJING, Nov. 18, 2024 /PRNewswire/ -- Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, and oncology, today announced that its investigational hepatitis D and B drug candidate, Libevitug (HH-003), an anti-PreS1 human monoclonal antibody, received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration...
Perennial Alzheimer’s Care Village Xi’an Positioned as China’s First and the World’s Sixth Alzheimer’s Care Village
Integrated Western and Eastern medicine, coupled with non-drug intervention therapies, sets international standards for Alzheimer's care in China SINGAPORE, Nov. 18, 2024 /PRNewswire/ -- Perennial Holdings Private Limited ("Perennial Holdings") is pleased that Perennial Alzheimer's Care Village ("PACV") in Xi'an, Shaanxi Province, positioned as China's first and the world's sixth Alzheimer's care village,...
New Report from Clarivate and Healthcare Executive Explores Mainland China’s Biopharma Revolution and Increasing Global Influence
New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON, Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A...
Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions
Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reduction, and up to 74% individual maximum and 56% mean maximal LDL-C lowering Robust and sustainable treatment effects support at least bi-annual dosing regimen Best-in-class potential of novel PCSK9 siRNA RN0191 supports further development as single agent or combination to further reduce atherosclerosis cardiovascular risk ...
Boehringer Ingelheim Commits to Veeva Vault CRM
Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches SINGAPORE, Nov. 18, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM. "We...
Sky Labs’ Wearable Device “Apollon” Recognized as an Honoree in CES 2025 Innovation Awards
SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ -- Sky Labs announced that its groundbreaking wearable device, Apollon, has been named an "Honoree" in the Artificial Intelligence category at the CES 2025 Innovation Awards. Hosted by the Consumer Technology Association (CTA)®, the CES Innovation Awards program annually recognizes outstanding achievements in design and engineering across 33 categories of consumer technology....
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors
TEL AVIV, Israel, Nov. 18, 2024 /PRNewswire/ -- SoniVie Ltd., a medical device company developing a proprietary renal denervation system to treat hypertension, announced today the appointment of Raymond W. Cohen to serve as its chairman of the board of directors. Mr. Cohen has served as the chief executive officer and member of the board of directors of Axonics, Inc.,...
